The Hypoferremic Response to Acute Inflammation is Maintained in Thalassemia Mice Even Under Parenteral Iron Loading

Overview

Journal PeerJ

Specialties Biology
Environmental Health
General Medicine

Date 2021 May 14

PMID 33987030

Authors

Chanita Sanyear

Buraporn Chiawtada

Punnee Butthep

Saovaros Svasti

Suthat Fucharoen

Patarabutr Masaratana

Affiliations

Soon will be listed here.

Abstract

Background: Hepcidin controls iron homeostasis by inducing the degradation of the iron efflux protein, ferroportin (FPN1), and subsequently reducing serum iron levels. Hepcidin expression is influenced by multiple factors, including iron stores, ineffective erythropoiesis, and inflammation. However, the interactions between these factors under thalassemic condition remain unclear. This study aimed to determine the hypoferremic and transcriptional responses of iron homeostasis to acute inflammatory induction by lipopolysaccharide (LPS) in thalassemic ( ) mice with/without parenteral iron loading with iron dextran.

Methods: Wild type and mice were intramuscularly injected with 5 mg of iron dextran once daily for two consecutive days. After a 2-week equilibration, acute inflammation was induced by an intraperitoneal injection of a single dose of 1 µg/g body weight of LPS. Control groups for both iron loading and acute inflammation received equal volume(s) of saline solution. Blood and tissue samples were collected at 6 hours after LPS (or saline) injection. Iron parameters and mRNA expression of hepcidin as well as genes involved in iron transport and metabolism in wild type and mice were analyzed and compared by Kruskal-Wallis test with pairwise Mann-Whitney U test.

Results: We found the inductive effects of LPS on liver IL-6 mRNA expression to be more pronounced under parenteral iron loading. Upon LPS administration, splenic erythroferrone (ERFE) mRNA levels were reduced only in iron-treated mice, whereas, liver bone morphogenetic protein 6 (BMP6) mRNA levels were decreased under both control and parenteral iron loading conditions. Despite the altered expression of the aforementioned hepcidin regulators, the stimulatory effect of LPS on hepcidin mRNA expression was blunt in iron-treated mice. Contrary to the blunted hepcidin response, LPS treatment suppressed FPN1 mRNA expression in the liver, spleen, and duodenum, as well as reduced serum iron levels of mice with parenteral iron loading.

Conclusion: Our study suggests that a hypoferremic response to LPS-induced acute inflammation is maintained in thalassemic mice with parenteral iron loading in a hepcidin-independent manner.

References

Vulpe C, Kuo Y, MURPHY T, Cowley L, Askwith C, Libina N . Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat Genet. 1999; 21(2):195-9. DOI: 10.1038/5979. View

Agoro R, Taleb M, Quesniaux V, Mura C . Cell iron status influences macrophage polarization. PLoS One. 2018; 13(5):e0196921. PMC: 5957380. DOI: 10.1371/journal.pone.0196921. View

Gao J, Chen J, Kramer M, Tsukamoto H, Zhang A, Enns C . Interaction of the hereditary hemochromatosis protein HFE with transferrin receptor 2 is required for transferrin-induced hepcidin expression. Cell Metab. 2009; 9(3):217-27. PMC: 2673483. DOI: 10.1016/j.cmet.2009.01.010. View

Gallitz I, Lofruthe N, Traeger L, Baumer N, Hoerr V, Faber C . Deficiency of the BMP Type I receptor ALK3 partly protects mice from anemia of inflammation. BMC Physiol. 2018; 18(1):3. PMC: 6389079. DOI: 10.1186/s12899-018-0037-z. View

Hoeft K, Bloch D, Graw J, Malhotra R, Ichinose F, Bagchi A . Iron Loading Exaggerates the Inflammatory Response to the Toll-like Receptor 4 Ligand Lipopolysaccharide by Altering Mitochondrial Homeostasis. Anesthesiology. 2017; 127(1):121-135. PMC: 5478432. DOI: 10.1097/ALN.0000000000001653. View

Besson-Fournier C, Latour C, Kautz L, Bertrand J, Ganz T, Roth M . Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood. 2012; 120(2):431-9. DOI: 10.1182/blood-2012-02-411470. View

Stefanova D, Raychev A, Arezes J, Ruchala P, Gabayan V, Skurnik M . Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron. Blood. 2017; 130(3):245-257. PMC: 5520472. DOI: 10.1182/blood-2017-03-772715. View

Nemeth E, Valore E, Territo M, Schiller G, Lichtenstein A, Ganz T . Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein. Blood. 2002; 101(7):2461-3. DOI: 10.1182/blood-2002-10-3235. View

Vento S, Cainelli F, Cesario F . Infections and thalassaemia. Lancet Infect Dis. 2006; 6(4):226-33. DOI: 10.1016/S1473-3099(06)70437-6. View

10.

Kautz L, Jung G, Valore E, Rivella S, Nemeth E, Ganz T . Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet. 2014; 46(7):678-84. PMC: 4104984. DOI: 10.1038/ng.2996. View

11.

Meynard D, Kautz L, Darnaud V, Canonne-Hergaux F, Coppin H, Roth M . Lack of the bone morphogenetic protein BMP6 induces massive iron overload. Nat Genet. 2009; 41(4):478-81. DOI: 10.1038/ng.320. View

12.

Goswami T, Andrews N . Hereditary hemochromatosis protein, HFE, interaction with transferrin receptor 2 suggests a molecular mechanism for mammalian iron sensing. J Biol Chem. 2006; 281(39):28494-8. DOI: 10.1074/jbc.C600197200. View

13.

Simpson R, Peters T . Forms of soluble iron in mouse stomach and duodenal lumen: significance for mucosal uptake. Br J Nutr. 1990; 63(1):79-89. DOI: 10.1079/bjn19900093. View

14.

Tanno T, Porayette P, Sripichai O, Noh S, Byrnes C, Bhupatiraju A . Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells. Blood. 2009; 114(1):181-6. PMC: 2710947. DOI: 10.1182/blood-2008-12-195503. View

15.

Yu P, Hong C, Sachidanandan C, Babitt J, Deng D, Hoyng S . Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. Nat Chem Biol. 2007; 4(1):33-41. PMC: 2727650. DOI: 10.1038/nchembio.2007.54. View

16.

Lakhal S, Schodel J, Townsend A, Pugh C, Ratcliffe P, Mole D . Regulation of type II transmembrane serine proteinase TMPRSS6 by hypoxia-inducible factors: new link between hypoxia signaling and iron homeostasis. J Biol Chem. 2010; 286(6):4090-7. PMC: 3039360. DOI: 10.1074/jbc.M110.173096. View

17.

Teawtrakul N, Jetsrisuparb A, Sirijerachai C, Chansung K, Wanitpongpun C . Severe bacterial infections in patients with non-transfusion-dependent thalassemia: prevalence and clinical risk factors. Int J Infect Dis. 2015; 39:53-6. DOI: 10.1016/j.ijid.2015.09.001. View

18.

Higgs D, Engel J, Stamatoyannopoulos G . Thalassaemia. Lancet. 2011; 379(9813):373-83. DOI: 10.1016/S0140-6736(11)60283-3. View

19.

Andriopoulos Jr B, Corradini E, Xia Y, Faasse S, Chen S, Grgurevic L . BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat Genet. 2009; 41(4):482-7. PMC: 2810136. DOI: 10.1038/ng.335. View

20.

Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt S, Moynihan J . Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature. 2000; 403(6771):776-81. DOI: 10.1038/35001596. View